Structure Therapeutics

Company snapshot

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, fe

• 13 active pipeline program(s) linked via ClinicalTrials.gov.
• 93 US patent(s) indexed to this assignee profile.
• 13 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Structure Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Structure Therapeutics.

1. Jun 8, 2026 Clinical update

   GSBR-1290-07 — Phase 1

2. Jun 8, 2026 Clinical update

   Aleniglipron — Phase 2

3. Jun 5, 2026 Clinical update

   TG-0054 combined with G-CSF — Phase 2

4. Jun 5, 2026 Clinical update

   GSBR-1290 (Capsule/Tablet) — Phase 1

5. Jun 5, 2026 Clinical update

   Aleniglipron or Placebo — Phase 2

View all clinical trial activity →

• What is Structure Therapeutics?

  Structure Therapeutics is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker GPCR. Primary therapeutic focus areas include Multiple Myeloma, Not applicable - Healthy volonteers, Obese, Obesity, Obesity, Overweight, or Chronic Weight Ma

• Is Structure Therapeutics publicly traded?

  Yes. Structure Therapeutics is listed with ticker GPCR on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Structure Therapeutics develop or market?

  We link 7 drug profile(s) where Structure Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/structure-therapeutics#company-drugs.

• What are the latest developments for Structure Therapeutics?

  In the last 12 months our linked public records show 13 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Structure Therapeutics focus on?

  Structure Therapeutics focuses on Multiple Myeloma, Not applicable - Healthy volonteers, Obese based on our analysis of their pipeline programs and drug development activities.